Vireo Growth (VREOF) EBITDA Margin (2020 - 2026)
Vireo Growth's (VREOF) quarterly EBITDA Margin came in at 9.51% in Q1 2026, up 94.0% year-on-year from 4.9% in Q1 2025, and up 16.85% quarter-over-quarter from 8.14% in Q4 2025.
Vireo Growth (VREOF) EBITDA Margin (2020 - 2026) Analysis & Trends
Vireo Growth has disclosed EBITDA Margin across 7 years of filings, most recently posting 9.51% for Q1 2026.
- EBITDA Margin for Q1 2026 came in at 9.51%, up 94.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 5.23% (down 591.0% YoY), and the FY2025 annual result was 3.83%, down 1011.0% from the prior year.
- EBITDA Margin came in at 9.51% for Q1 2026 at Vireo Growth, up from 8.14% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 24.2% in Q3 2023 to a low of 48.62% in Q1 2022.
- The 5-year median for EBITDA Margin is 4.56% (2022), against an average of 4.9%.
- Across the five-year window, EBITDA Margin surged 6423 bps in 2022 and tumbled 2676 bps in 2025, its largest moves.
- Vireo Growth's EBITDA Margin stood at 4.56% in 2022, then jumped by 397 bps to 22.65% in 2023, then sank by 114 bps to 3.08% in 2024, then surged by 364 bps to 8.14% in 2025, then increased by 17 bps to 9.51% in 2026.
- The last three EBITDA Margin figures came in at 9.51% (Q1 2026), 8.14% (Q4 2025), and 1.49% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 16.37% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 36.83% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 41.69% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | -1.01% |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 22.74% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 22.39% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -170.35% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -16.25% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 21.55% |
| 10 | Vireo Growth | - | - | 59.30 Mn | 9.51% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.51% |
| Dec 31, 2025 | 8.14% |
| Sep 30, 2025 | 1.49% |
| Jun 30, 2025 | -3.39% |
| Mar 31, 2025 | 8.57% |
| Dec 31, 2024 | -3.08% |
| Sep 30, 2024 | 15.61% |
| Jun 30, 2024 | 23.37% |
| Mar 31, 2024 | 20.06% |
| Dec 31, 2023 | 22.65% |
| Sep 30, 2023 | 24.20% |
| Jun 30, 2023 | -4.58% |
| Mar 31, 2023 | 2.77% |
| Dec 31, 2022 | 4.56% |
| Sep 30, 2022 | -0.11% |
| Jun 30, 2022 | 2.23% |
| Mar 31, 2022 | -48.62% |
| Dec 31, 2021 | -59.68% |
| Sep 30, 2021 | -30.16% |
| Jun 30, 2021 | -21.09% |